Zhen‐Chong Yang

机构：Sun Yat-sen University, Sun Yat-sen University Cancer Center · ORCID：0000-0001-9065-5315

发表论文 22 篇 · 总被引 434 次 · h-index 8

代表论文

• EBV infection-induced GPX4 promotes chemoresistance and tumor progression in nasopharyngeal carcinoma (2022 · Cell Death and Differentiation · 被引 155)
• Optimal cumulative cisplatin dose in nasopharyngeal carcinoma patients based on induction chemotherapy response (2019 · Radiotherapy and Oncology · 被引 69)
• Concurrent chemoradiotherapy followed by adjuvant cisplatin–gemcitabine versus cisplatin–fluorouracil chemotherapy for N2–3 nasopharyngeal carcinoma: a multicentre, open-label, randomised, controlled, phase 3 trial (2023 · The Lancet Oncology · 被引 41)
• Comparing three induction chemotherapy regimens for patients with locoregionally advanced nasopharyngeal carcinoma based on TNM stage and plasma Epstein–Barr virus DNA level (2020 · BMC Cancer · 被引 34)
• Reduced-dose radiotherapy for Epstein-Barr virus DNA selected staged III nasopharyngeal carcinoma: A single-arm, phase 2 trial (2023 · European Journal of Cancer · 被引 33)
• Effect of Concurrent Chemoradiotherapy With Nedaplatin vs Cisplatin on the Long-term Outcomes of Survival and Toxic Effects Among Patients With Stage II to IVB Nasopharyngeal Carcinoma (2021 · JAMA Network Open · 被引 32)